GlassScriptPhysician profile
Emily E Chwa
NPI 1851076988
$440.86
in general payments reported to CMS, 2019-2025
10 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $109 · 2024: $138 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $134.22 | 2023-2025 | Nexplanon |
| Sage Therapeutics, LLC | $66.69 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $52.89 | 2024-2025 | Veozah |
| Myriad Women'S Health, INC. | $50.00 | 2023 | Myrisk |
| Supernus Pharmaceuticals, INC. | $32.77 | 2025 | Qelbree |
| Northgate Technologies, INC. | $28.62 | 2024 | Stimsite |
| Sumitomo Pharma America, INC. | $23.71 | 2024 | Myfembree |
| Hologic Sales and Service, LLC | $20.97 | 2025 | Aptima, Thinprep 2000 Processor |
| Integra Lifesciences Corporation | $16.78 | 2024 | Medihoney, Biodfactor, Biodrestore |
| Exact Sciences Corporation | $14.21 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Chwa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.